First Allied Advisory Services’s West Pharmaceutical WST Stock Holding History

First Allied Advisory Services’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$914K	Buy	3,326 +222	+7%	+$58.8K	0.03%	496
2020 Q2	$705K	Buy	3,104 +285	+10%	+$56K	0.03%	549
2020 Q1	$429K	Sell	2,819 -385	-12%	-$59.3K	0.02%	645
2019 Q4	$485K	Sell	3,204 -123	-4%	-$17.9K	0.02%	725
2019 Q3	$474K	Buy	3,327 +168	+5%	+$23.1K	0.02%	700
2019 Q2	$395K	Buy	3,159 +221	+8%	+$26.1K	0.01%	774
2019 Q1	$327K	Buy	+2,938	New	+$306K	0.01%	831
2018 Q4	–	Sell	-2,361	Closed	-$287K	–	1202
2018 Q3	$287K	Buy	2,361 +312	+15%	+$35K	0.01%	927
2018 Q2	$200K	Buy	+2,049	New	+$189K	0.01%	1057

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

First Allied Advisory Services's WST Position: Q3 2020 in Review

First Allied Advisory Services increased its West Pharmaceutical (WST) stake by 7.2% in Q3 2020, buying an estimated $58.8K and bringing the position to 3,326 shares worth $914K. The position accounts for 0.03% of the portfolio, ranked #496.

First Allied Advisory Services first reported a position in WST in Q2 2018 and has held it in 9 quarters since. 574 funds tracked by Wall St. Rank hold WST as of Q3 2020.

First Allied Advisory Services held 3,326 shares of West Pharmaceutical worth $914K as of Q3 2020.
First Allied Advisory Services bought 222 West Pharmaceutical shares in Q3 2020, an estimated $58.8K.
West Pharmaceutical made up 0.03% of First Allied Advisory Services's portfolio in Q3 2020, its #496 holding.
First Allied Advisory Services first reported a position in West Pharmaceutical in Q2 2018 and has held it in 9 quarters since.
574 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.